The 5HT uptake inhibitor fluoxetine had no effect on motor activity or directed exploration (head-dipping) in a holeboard test or in an elevated plusmaze test of anxiety. Fluoxetine (20 mg/kg) attenuated the anxiolytic effect of a 2.4 g/kg dose of ethanol in the plusmaze but failed to alter ethanol's effects on exploratory head-dipping or locomotion. This interaction did not seem directly related to fluoxetine's 5HT uptake inhibiting properties because it was not observed with other 5HT uptake inhibitors (fluvoxamine and citalopram). Desipramine, which predominantly inhibits noradrenaline uptake, also failed to show effects similar to those of fluoxetine.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Amit Z, Sutherland A, Gill K, Ogren SO (1984) Zimeldine: a review of its effects on ethanol consumption. Neurosci Biobehav Rev 8:35–54
Bucher T, Redetzki H (1951) Eine photometrische Bestimmung von Athylalkohol auf fermentativem Wege. Klin Wochenschr 29:615–621
Durcan MJ, Lister RG (1988) Time course of ethanol's effects on locomotor activity, exploration and anxiety in mice. Psychopharmacology 96:67–72
Essman WB (1968) Differences in locomotor activity and brain serotonin metabolism in differentially housed mice. J Comp Physiol Psychol 66:244–246
File SE, Wardill AG (1975) Validity of head-dipping as a measure of exploration in a modified holeboard. Psychopharmacology 44:53–59
Geller I (1973) Effects of para-chlorophenylalanine and 5-hydroxytryptophan on alcohol intake in the rat. Pharmacol Biochem Behav 1:361–365
Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model for fear-motivated behaviour. Naunyn Schmiedeberg's Arch Pharmacol 327:1–5
Hill SY (1974) Intraventricular injection of 5-hydroxytryptamine and alcohol consumption in rats. Biol Psychiatry 8:151–158
Lasley SM, Thurmond JB (1985) Interaction of dietary tryptophan and social isolation on territorial aggression, motor activity and neurochemistry in mice. Psychopharmacology 87:313–321
Lawrin MO, Naranjo CA, Sellers EM (1986) Identification and testing of new drugs for modulating alcohol consumption. Psychopharmacol Bull 33:1020–1025
Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185
Lister RG (1988) Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety. Pharmacol Biochem Behav (in press)
Lister RG, Durcan MJ, Eckardt MJ, Linnoila M (1986) Behavioral pharmacology of interactions between alcohol and serotonin uptake inhibitors in experimental animals. Clin Neuropharmacol [Suppl 4] 9:52–54
Myers RD, Martin GE (1973) The role of cerebral serotonin in the ethanol preference of animals. Ann NY Acad Sci 215:135–140
Naranjo CA, Sellars EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K (1984) Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers. Clin Pharmacol Ther 35:374–381
Ortmann R, Waldmeier PC, Radeke E, Felner A, Delini-Stula A (1980) The effects of 5-HT uptake and MAO-inhibitors on L-5-HTP induced excitation in rats. Naunyn Schmiedeberg's Arch Pharmacol 311:185–192
Pellow S, Chopin P, File SE, Briley M (1985) Validation of closed: open arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
Pohorecky L (1977) Biphasic action of ethanol. Biobehav Rev 1:231–240
Pohorecky L (1981) The interaction of alcohol and stress: a review. Neurosci Biobehav Rev 5:209–229
Rockman GE, Amit Z, Brown ZW, Bourque C, Ogren S-O (1982) An investigation of the mechanisms of action of 5-hydroxytryptamine in the suppression of ethanol intake. Neuropharmacology 21:341–347
Schenk S, Hunt T, Malovechko R, Robertson A, Klukowski G, Amit Z (1986) Differential effects of isolation housing on the conditioned place preference produced by cocaine and amphetamine. Pharmacol Biochem Behav 24:1793–1796
Stark P, Fuller R, Wong DT (1985) The pharmacologic profile of fluoxetine. J Clin Psychiatry 46:7–13
Welch BL, Welch AS (1968) Differential activation by restraint stress of a mechanism to conserve brain catecholamines and serotonin in mice differing in excitability. Nature 218:575–577
Wong DT, Horng JS, Bymaster FP, Hauser KL, Molloy BB (1974) A serotonin uptake specific inhibitor: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci 15:471–479
Wong DT, Bymaster FP, Horng JS, Molloy BB (1975) A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. J Pharmacol Exp Ther 193:804–811
Zabik JE, Binkerd K, Roache JD (1985) Serotonin and ethanol aversion in the rat. In: Naranjo CA, Sellers EM (eds) Research advances in new psychopharmacological treatments for alcoholism. Elsevier, Amsterdam, pp 87–101
About this article
Cite this article
Durcan, M.J., Lister, R.G., Eckardt, M.J. et al. Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration. Psychopharmacology 96, 528–533 (1988). https://doi.org/10.1007/BF02180035
- 5HT Uptake inhibitors
- Locomotor activity